Acuired by Amgen 10/3/23. Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The Company pipeline is purposeful: it applyie scientific expertise and courages to bring clinically meaningful therapies to patients. The Company believes science and compassion must work together to transform lives. Show more

Location: | Website: www.horizontherapeutics.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$116.30

Open

$116.30

Volume

N/A

Day Range

$116.30 - $116.30

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

1.18%

Institutional Own.

-

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date